# US 2012/0252722 A1 · Metal-binding therapeutic peptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252722 A1
- Document ID: US20120252722A1
- Status: Published application
- Kind: A1
- Application number: 13/165,688
- Filed: 2011-06-21
- Published: 2012-10-04
- Earliest claimed: 2005-11-09
- Inventors: Desmond MASCARENHAS
- Web page: https://patentgrep.com/patent/US20120252722A1

## CPC

- A61K 38/10: Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/12: of the kidneys
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.

## Claims

### Claim at position 1

1-36. (canceled)

### Claim 37

A polypeptide comprising the sequence SDKPDMAPRGFSCLLLLTGEIDLPV (SEQ ID NO:245).

### Claim 38 (depends on 37)

A composition comprising the polypeptide of claim 37 and a pharmaceutical excipient.

### Claim 39 (depends on 37)

A nucleic acid encoding the polypeptide of claim 37.

### Claim 40 (depends on 39)

A vector comprising the nucleic acid of claim 39.

### Claim 41

A method of treating an inflammatory disease condition comprising administering an effective amount of a polypeptide to a mammal, wherein said polypeptide comprises and amino acid sequence selected from the group consisting of SDKPDMAPRGFSCLLLLTGEIDLPV (SEQ ID NO:245), humanin (SEQ ID NO:188), and humanin-S14G (SEQ ID NO:189); and said inflammatory disease condition is selected from the group consisting of cancer, cardiomyopathy, nephropathy, retinopathy, obesity, lupus, autoimmune disease, rheumatological disease and infectious disease.

### Claim 42 (depends on 41)

The method of claim 41, wherein the nephropathy is diabetic nephropathy.

### Claim 43 (depends on 41)

The method of claim 41 wherein the polypeptide is administered via a route selected from the group consisting of intravenous, oral, subcutaneous, intraarterial, intramuscular, intracardial, intraspinal, intrathoracic, intraperitoneal, intraventricular, sublingual, transdermal, and inhalation.

### Claim 44 (depends on 39)

A method of treating an inflammatory disease condition comprising administering the nucleic acid of claim 39 to a mammal; said inflammatory disease condition is selected from the group consisting of cancer, diabetes, cardiovascular disease, kidney disease, retinopathy, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, lupus, autoimmune disease, rheumatological disease and infectious disease.
